- Query in any language with multilingual search
- Access EUR-Lex and EU Commission case law
- See relevant paragraphs highlighted instantly
Similar Documents
Explore similar documents to your case.We Found Similar Cases for You
GLAXOSMITHKLINE / NOVARTIS VACCINES BUSINESS (EXCL. INFLUENZA) / NOVARTIS CONSUMER HEALTH BUSINESS
M.7276
With us you find everything. Try it now!
I imagine what I want to write in my case, I write it in the search engine and I get exactly what I wanted. Thank you!
Valentina R., lawyer
On 12 February 2015 the Commission approved the appointment of:
Duff & Phelps B.V.
Rembrandt Tower, Amstelplein 1
1096 HA Amsterdam
The Netherlands
+31 20 851 5175; +31 20 851 5185
jan.jaap.snel@duffandphelps.com; astrid.bellon@duffandphelps.com
as Monitoring Trustee in the above-mentioned case in relation to Vaccines (2 Commitments regarding MenACWY and dT).
On 13 February 2015 the Commission approved the appointment of:
Grant Thornton UK LLP
30 Finsbury Square
London
EC2P 2YU
+44 (0)20 7383 5100
mark.r.byers@uk.gt.com; craig.reed@uk.gt.com
as Monitoring Trustee in the above-mentioned case in relation to Consumer Health (5 Commitments in the following product areas: smoking cessation, cold sore management, cold and flu remedies and pain management).
The role of the Monitoring Trustees is to monitor the compliance of GSK with the Commitments attached to the Commission's Decision of 28 January 2015 and to report to the Commission thereon.
Third parties who have queries in relation to the Commitments may contact the relevant Trustee through the above contact details.
The foregoing is without prejudice to the Commission's jurisdiction to oversee the implementation of the Commitments attached to its Decision.